2024 PrevMed3Lab Trans02 HumanSexuality
2024 PrevMed3Lab Trans02 HumanSexuality
I. OVERVIEW
1 | Page
with a screening or abbreviated method followed ● Slang words should be redefined in medical
by in-depth questioning if necessary (Table 42-1). terminology so that the clinician and patient may
● The answers on the detailed sexual history then communicate clearly.
direct the physical examination and appropriate ● PLISSIT model
laboratory testing. ○ Proposed by Jack Annon in 1976,
○ Used to approach sexual concerns:
Permission, Limited Information, Specific
Suggestions, and Intensive Treatment (Table
42-2).
2 | Page
medical condition or treatment for a ○ Discord or communication difficulty in a
medical condition couple’s relationship
○ an individual’s understanding of sexual
functioning must be assessed EVALUATION
○ Occasionally, they simply lacks the ● Thorough history and physical examination
knowledge or an understanding of the ● Laboratory testing
normal decrease in sexual response ○ thyroid function -fasting glucose
associated with aging and needs ○ lipid profile -liver
education function
● If a hormonal problem is suspected
III. FEMALE SEXUAL DYSFUNCTION ○ Prolactin, total and free testosterone, sex
hormone–binding globulin,
FEMALE SEXUAL INTEREST/AROUSAL DISORDER dehydroepiandrosterone (DHEA), and
● Low sexual interest estrogen levels
○ Most frequently reported sexual problem. ● Androgen levels
○ 4 in 10 women have low sexual desire ○ Measured at the peak on days 8-10 of a
● Hypoactive sexual desire disorder (DSM-IV-TR) 28-day menstrual cycle in
● Female sexual interest/arousal disorder (DSM-5) premenopausal women
○ A woman needs to lack or have
significantly reduced sexual interest or FEMALE ORGASMIC DISORDER
arousal for at least a 6-month duration TREATMENT
○ Manifested by at least three of six criteria ● No U.S. FDA approved medication
● Estrogen therapy improves vaginal dryness
● Estrogen alone or in combination with
progesterone
○ Women within 5 years of amenorrhea
(early menopause)
● Ginkgo biloba, damiana leaf, ginseng, and other
proprietary herbal blends
○ Limited data exist
● Psychosocial interventions
○ Reported efficacious for the treatment of
female sexual dysfunction
● Orgasmic dysfunction
○ the inability to reach orgasm when desired
○ may be lifelong or acquired
● Women must have experienced a marked delay in
orgasm, marked infrequency of or absence of
orgasm, and markedly reduced intensity of
● Female sexual desire orgasmic sensations over a 6-month time frame
○ A complex interaction among biologic, ● Must express clinically significant distress regarding
psychological, social, interpersonal, and the diminished orgasmic sensations
environmental components.
EVALUATION
○ Ovarian function (ovarian androgens),
● Clinical history in acquired orgasmic disorder
may play an important role
○ patient’s perception of this dysfunction
● Factors that may diminish sexual interest or arousal
○ the time and circumstances of onset,
○ Life stressors, health problems, and
possible causes,
personality
○ effect on relationship(s), and treatment
○ Thyroid disease, chronic pain conditions,
goals.
urinary incontinence, and depression or
● Physiologic functioning during sexual stimulation
anxiety
● Contributing factors
○ SSRI antidepressants, antihypertensives,
○ fatigue, depression, stress, substance
antipsychotics, and narcotics
abuse, and other medical illnesses
○ Fear of pregnancy or sexually transmitted
● Contextual and relationship issues
infection (STI)
● SSRIs may delay or inhibit orgasm in women.
3 | Page
● No specific physical examination or laboratory IV. MALE SEXUAL DYSFUNCTION
testing is necessary
ERECTILE DYSFUNCTION
GENITO-PELVIC PAIN/PENETRATION DISORDER
● “the inability for a male to achieve an erect penis
Four commonly comorbid symptoms: as part of the overall multifaceted process of male
1. Difficulty having intercourse sexual function.” (NIHCDC, 1992)
● “erectile disorder” accompanied by “clinically
2. Genito-pelvic pain
significant distress” (DSM-5)
3. Fear of pain or vaginal pain
○ Not better accounted for by a nonsexual
4. Tension of the pelvic floor muscles mental health disorder of the direct
physiologic effects of a substance or a
Genito-pelvic pain is often idiopathic but may follow general medical condition
pelvic trauma, such as: ● Occur at any age, prevalence increases with age
● Painful intercourse ○ 2% (40-49 y/o), 6% (50-59 y/o), 17% (60-69
● Childhood or adolescent sexual abuse y/o, 39% (70 y/o)
● Sexual assault ● Associated with: DM, CAD, CVD, HPN
● Rough gynecologic examination ● Other contributing factors: Smoking, sedentary
● Complicated episiotomy lifestyle overweight
● Vaginal infections
● Pelvic inflammatory disease EVALUATION
● Pelvic surgery ● Some men consider PE as ED
● Check Medicines
EVALUATION ● Social History: smoking, alcohol, drug and
● Diagnosis: History marijuana use and important social and sexual
relationships
● Important risk factor: Pain during tampon insertion
● Psychological factors: depression and anxiety
or the inability to insert a tampon
● Physical activity: bicycle riding (decreased penile
● Pain and difficulty with, or inability to engage in, blood flow from perineal compression)
vaginal intercourse or digital vaginal stimulation,
using tampons or vaginal contraceptives, or
having a pelvic examination
● Speculum exam: Visible contraction of the pelvic
floor musculature
● Physical exam: Pertinent anatomic abnormalities
(vaginal septa)
TREATMENT
● Vaginal muscle tightening or spasm: restoring
conscious control of vaginal muscle relaxation
● Expresses fear or anxiety: pelvic examination may
be deferred
○ Severe cases: sedation
● Any physical abnormalities detected (infections),
should first be treated
● Self treatment (size-graded plastic or silicone
vaginal dilators)
○ Vagina remain relaxed and receive
nonpainful, self-controlled penetration
● Specialized PT: Patients use biofeedback to relax
the pelvic floor musculature PHYSICAL EXAMINATION
● vascular, neurologic, and endocrine systems
○ Peripheral pulses and carotid
○ Thyroid enlargement or nodular diseases
4 | Page
● Genitourinary examination diagnosis of delayed ejaculation disorder
○ perineal innervation with anal sphincter
tone, perianal sensation, and the CAUSES
bulbocavernosus reflex ● Alcohol use
○ Penile shaft (Peyronie disease) ● Contextual issues
○ Prostate and testicle (atrophy), signs of ● Partner issues
hypogonadism
● Glucose, lipid profile, BUN, creatinine, serum V. SUBSTANCE− OR MEDICATION− INDUCED SEXUAL DYSFUNCTION
TREATMENT
● Selective serotonin reuptake inhibitors
● PDE-5 Inhibitors
● Topical eutectic mixture of lidocaine- prilocaine
spray
DELAYED EJACULATION
● Diagnosed when the man has adequate sexual
stimulation and the desire to ejaculate but
subjectively has a delay or absence of ejaculation
● Fewer than 1% of men complains of delayed
ejaculation listing the 6 months needed for the
5 | Page
VII. SEXUALITY ISSUES AT SPECIFIC TIMES OF LIFE
LESBIAN
● Lesbians are less likely to obtain health
maintenance services (mammography and ADOLESCENCE
cervical cancer screening) than heterosexual Sexual Activity
women ● Teenagers may practice sexual acts other than
● Nulliparous lesbians intercourse
○ High risk for cancers of the breast, ○ mutual genital touching
endometrium, and ovary ○ masturbation
● Female-to-female transmission of STIs is much less ○ oral sex
efficient than male-to-female transmission ● Remind sexually active adolescents to use a
● Genital–oral sex and fomites (sex toys) condom
○ Can transmit gonorrhea and Trichomonas ● 47% of all students had sexual intercourse
● Mental health screening for depression and suicide ● 15% of teenagers had four or more sexual partners
should be considered, especially for “closeted” ● Do not assume that adolescent sexual experiences
sexual minority women are consensual or desired
● Lesbians who had not disclosed their sexual ● Drug and alcohol use is a significant risk factor for
orientation to a majority of friends, family, and unprotected sexual activity
coworkers were 90% more likely to have ever ● Referral for treatment of addiction
made a suicide attempt ○ drinking with driving or sex
○ unable to discontinue this risk behavior
GAY MEN without assistance
● Gay men sometimes report difficulty in obtaining ● Long-acting contraception - young women who
adequate health care caused by providers’ bias are at risk for pregnancy because of substance
and fear of discrimination use
● Men who self-identify as gay or bisexual are more
LGBTQ
likely than heterosexual men
● Lesbian, Gay, Bisexual, and Transgender and
○ To have major depression
Questioning Youth
○ To admit to suicidal ideation
● 3 dimensions of sexual orientation
○ To have attempted suicide
○ Attraction
TRANSGENDERED PATIENTS ○ Self-identification
● Transgendered individuals transiently or persistently ○ Sexual behavior
identify with a gender different than their natal ● “Questioning” - uncertain of their sexual orientation
gender ● Maintain an open questioning style
● A transsexual individual
Gender Dysphoria
○ One who seeks to take on the social role of
● By 3 or 4 years, a child self identifies as a boy or girl
the other gender, either full or part time,
● some children may express gender dysphoria as
often with the assistance of hormone
early as preschool
therapy, surgery, or both
● Gender dysphoric adolescents may have more
● Cross-dressers (previously referred to as
anxiety and depression or oppositional defiant
“transvestites”)
disorder than non– gender dysphoric adolescents
○ Persons who at times may dress as the
other gender to be publicly perceived as Health Risks for LGBTQ Youth
such or for sexual pleasure. ● harassment, profound isolation, and fear of
● Intersex discovery
○ Persons born with ambiguous genitalia or ● Censure, alienation, and abandonment by the
for whom phenotypic and chromosomal family of origin
sex do not match ● more likely to
● Gender dysphoria is clinically distressing ○ have had sexual intercourse
incongruence between one’s natal gender and ○ have had three or more sexual partners
one’s expressed or experienced gender ○ experience sexual intercourse against their
○ People may seek medical assistance in will
changing their physical sex to be ○ start using tobacco, alcohol, and illegal
congruent with their internal drugs at an earlier age
self-perception
6 | Page
● become pregnant than their heterosexual peers significant vaginal atrophy through continued
● sexual activity while under the influence of drugs or stimulation of the epithelium and vascular supply
alcohol ● Testosterone levels do decline with age, eventually
● half as likely to use a condom by 50% from midlife to old age.
● Depression and suicide ● Testosterone levels are lower in men with chronic
illnesses than healthy men
OLDER ADULTHOOD ● Signs and symptoms of low testosterone levels:
● The likelihood of being sexually active correlates ○ increased abdominal fat - reduced muscle
with good health status. and bone mass
● Testosterone levels are lower in men with chronic ○ decreased body hair - Gynecomastia
illnesses than in healthy men ○ small testis - Fatigue
● Before testosterone replacement, men should ○ Weakness - decreased libido
have their prostates evaluated with a PSA and ○ decreased energy - erectile dysfunction
digital rectal examination. ● Low testosterone levels associated with signs and
● the likelihood of being sexually active declines symptoms compromise the clinical syndrome of
steadily with age, many older adults remain late-onset hypogonadism, also called androgen
sexually active deficiency in the aging male or colloquially “low
● The likelihood of being sexually active is associated T.”
with good health ● Testosterone levels above 12 nmol/L (346 ng/dL)
● Common health conditions that can inhibit sexual do not need supplementation
activity ● In obese men, weight loss and increased physical
○ Arthritis or back pain activity can raise testosterone levels
○ Vascular disease and its risk factors ● Before testosterone replacement therapy (TRT),
(correlate with ED) men should be screened with a PSA and a digital
■ CAD rectal examination and then have a PSA drawn
■ Stroke annually
■ Diabetes ○ A PSA rise of 0.4 ng/mL over 2 years or an
■ Hypertension incremental rise of 1.4 ng/mL in 1 year
■ Hyperlipidemia should trigger further urologic examination
■ smoking ● Testosterone for replacement can be administered
○ Pudendal nerve disruption after intramuscularly, subcutaneously, or transdermally
hysterectomy and bladder, rectal, or ● Testosterone supplementation appears to have
prostate surgery increased risk for men with cardiovascular disease.
● At all ages, women are less likely to be sexually
active than men. VIII. CONCLUSION
● For women who reported no sexual activity in the
previous 3 months: ● Sexuality is a core aspect of personal identity
○ lack of interest - most common reason ● Many patients with sexual problems can be
○ lack of a sexual partner treated by family physicians and other primary
○ physical problem of the partner health care providers without assistance
○ lack of interest by the partner ● Family physicians should maintain awareness of
● Between 75 and 85 years, men are almost twice as the health care needs of persons with
likely as women to have an intimate partner same-gender sexual experiences or orientation
● A decline in sex steroid production is a factor in ● Sexual health issues are pertinent for adolescent
sexual dysfunction for both women and men and older adult wellhealth care
● Postmenopausal estrogen deficiency is responsible ● Family physicians should routinely include
for loss of vaginal lubrication and elasticity questions regarding gender identity, sexual
● The Women’s Health Initiative raised concerns behavior, and relationships during the clinical
regarding deleterious effects of systemic estrogen interview of all patients to help maintain their
replacement optimum health.
○ Clinicians should counsel women desiring
long-term oral estrogen supplementation to IX. REFERENCE
diminish vaginal atrophy symptoms
regarding the increased risk of CAD, ● Reporters ppt
thrombotic disease, and breast cancer
● Women who remain sexually active may avoid
7 | Page